Tatva Chintan Pharma Chem Ltd 2023 AR2
The report highlights Tatva Chintan Pharma Chem Limited's performance for the fiscal year 2022-23, during which the company navigated global economic challenges and supply chain disruptions. Key achievements include the completion of the Dahej plant expansion, increasing reactor capacity by 70% and assembly lines by 44%, with commercial production commencing in April 2023. The company also expanded its R&D facility in Vadodara, introducing 15 new products. On the ESG front, the company achieved a 5.74% reduction in Scope 1 emissions and a 21.76% reduction in Scope 2 emissions, while recycling 41% of its water and 73.05% of its hazardous waste.
Company: Tatva Chintan Pharma Chem Ltd
Sector: Materials
Country: India
Year: 2023
Type: AR2
Pages: 271
Tatva Chintan Pharma Chem Ltd
Annual Report
The report highlights Tatva Chintan Pharma Chem Limited's performance for the fiscal year 2022-23, during which the company navigated global economic challenges and supply chain disruptions. Key achievements include the completion of the Dahej plant expansion, increasing reactor capacity by 70% and assembly lines by 44%, with commercial production commencing in April 2023. The company also expanded its R&D facility in Vadodara, introducing 15 new products. On the ESG front, the company achieved a 5.74% reduction in Scope 1 emissions and a 21.76% reduction in Scope 2 emissions, while recycling 41% of its water and 73.05% of its hazardous waste.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Apr 1, 2022 - Mar 31, 2023
Fiscal Year
2023
Published
Aug 4, 2023
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees